Structure drawing coming soon
nor-KC2
nor-KC2 is an ionizable cationic lipid structurally related to DLin-KC2-DMA (KC2), with the C18 linoleyl chains of KC2 replaced by shorter C17 chains. Like KC2, it features two hydrophobic chains connected through a 1,3-dioxolane ring to a dimethylaminoethyl head group.
The C17 chains are derived from commercially available methyl linoleate. This enables a shorter, more streamlined synthetic route than the original preparation of KC2. Published studies indicate that nor-KC2 can provide comparable or improved nucleic acid delivery performance relative to KC2.
nor-KC2 is used in siRNA and mRNA LNP formulation and in structure–activity work on ionizable lipid design, where the dioxolane scaffold makes it a useful counterpart to the ester-linked MC3 series. As with nor-MC3, the simpler synthesis is the practical draw: it makes the lipid easier to produce consistently and to scale up when a formulation moves beyond screening quantities.
- Formal name
- 2-[2,2-bis[(8Z,11Z)-heptadeca-8,11-dienyl]-1,3-dioxolan-4-yl]-N,N-dimethylethanamine (nor-KC2)
- CAS number
- Not yet registered
- Molecular formula
- C41H75NO2
- Formula weight
- 614.1 g/mol
- Purity
- ≥98% — confirmed by ¹H NMR, ¹³C NMR and LC-MS. N-oxide free.
- SMILES
CCCCC/C=C\C/C=C\CCCCCCCC1(OCC(O1)CCN(C)C)CCCCCCC/C=C\C/C=C\CCCCC- Storage
- Store at −20 °C under inert atmosphere, protected from light.
Package size
Quantity
Request a QuoteFor research use only — not for human or veterinary use.
References
- nor-MC3 and nor-KC2: cationic ionizable lipids for the delivery of therapeutic nucleic acidsRSC Pharmaceutics · 2026